M Sahni has her expertise in the management of critically ill premature infants,
with a special interest in newborn lung pathologies including Bronchopulmonary
Dysplasia and Pulmonary Hypertension. Her research over the past 3 years has
been focused on the evaluation of novel biomarkers in Bronchopulmonary Dysplasia
and their utility in the diagnosis and management of this disease. Her other
research projects have been focused on the role of various angiogenic markers in
hyperoxia-induced lung injury and understanding their role in Bronchopulmonary
Dysplasia.